Global Marasmus Treatment Market, By Treatment (Medication, Dietary Supplements and Nutritional Diet), Mechanism of Action (Antimicrobial Agents, Antiprotozoal Agents, Antipyretics, Analgesics and Others), (Route of Administration (Oral, Intravenous and Others), End User (Hospitals, Specialty Clinics, Diagnostic Centers and Others), Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies and Online Pharmacies) – Industry Trends and Forecast to 2030.
Marasmus Treatment Market Analysis and Size
As per the records of UNICEF, it estimates that around 3 million each year, nearly half of all deaths in children under the age of 5 years result from a lack of nutrition. Growing up in a developing country is a major risk factor for developing marasmus. Regions with famines or high poverty rates have increased percentages of children suffering from marasmus. Both adults and children can suffer from marasmus, but it commonly affects young children in developing countries. And hence, the treatment of these patients are on higher demand as it will help them in faster recovery. Hence the market is expected to rise rapidly.
Data Bridge Market Research analyses a growth rate in the marasmus treatment market in the forecast period 2023-2030. The expected CAGR of marasmus treatment market is tend to be around 6.40% in the mentioned forecast period. The market valued at USD 45.4 billion in 2022, and it would grow upto USD 74.6 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Marasmus Treatment Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Treatment (Medication, Dietary Supplements and Nutritional Diet), Mechanism of Action (Antimicrobial Agents, Antiprotozoal Agents, Antipyretics, Analgesics and Others), (Route of Administration (Oral, Intravenous and Others), End User (Hospitals, Specialty Clinics, Diagnostic Centers and Others), Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies and Online Pharmacies)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Par Pharmaceutical (U.S.), Groupe Lactalis (France), Nutricia (Netherlands), Fresenius SE & Co. KGaA (Germany), Abbott (U.S.), Altasciences (Canada), PepsiCo (U.S.), Nestlé, (Switzerland), Anaiah Healthcare Limited (U.K.), AYMES Nutrition (U.K.), Solvay (Belgium)
|
|
Market Opportunities
|
|
Market Definition
Marasmus is referred to as severe undernutrition, which underlines a deficiency in all the macronutrients the body necessitates to function, including carbohydrates, protein and fats. Marasmus causes prominent wasting of fat and muscle under the skin. It leads to stunted growth in children. People suffering from marasmus are visibly depleted, severely underweight and emaciated. Prolonged marasmus causes starvation. It is more prevalent in developing countries with extreme poverty and food scarcity, and where parasites and infectious diseases may contribute to calorie depletion.
Marasmus Treatment Market Dynamics
Drivers
- Rising Prevalence of Marasmus
Approximately 30% of humans currently suffer from one or more of the multiple forms of malnutrition. Nearly 50 million children younger than 5 years have PEM, and half of the children who die younger than 5 years are malnourished. It is more common in developing countries, such as in some areas of Asia and Africa. People in these nations are susceptible to having poor access to food, making it more difficult to get enough nutrients. Thus, this boost the growth of the treatment market.
- Increasing Demand of Direct Tender Channel
The direct tender segment is growing the marasmus treatment market since direct tender holds the largest market share along with the highest CAGR. It is majorly because of the service providers who buy the product from different manufacturers and it is witnessed that revenue from direct sales is more influential and increasing in the market.
Opportunities
- Growing Diagnostic Tests For Marasmus
Measures such as upper arm circumference and height-to-weight ratios assist the healthcare professionals to diagnose the severity of undernutrition. Height-to-age ratios help to understand growth delays in children. Additionally, blood test are widely used to identify the secondary effects of marasmus, which includes specific vitamin, enzyme, mineral, and electrolyte deficiencies. This will help define the child’s or adult’s nutritional needs for refeeding. Also, a complete blood count can also help in showing any infections or diseases that may have contributed to marasmus. Thus, this boost the market growth.
- Increasing Demand of Nutritional Rehabilitation
Nutritional rehabilitation is growing and increasing the demand of the market. Refeeding begins gradually with liquid formulas that carefully balance proteins, carbohydrates, and fats. For inpatients, healthcare professionals favour tube feeding since it enables for gradual but continuous nutrition. Calories are introduced at around 70% of normal recommended values for the person’s age. In the end, they may increase to 140% of recommended values to meet the growth requirements of stunted children. Patients slowly progress to more ordinary oral feeding with solid foods during this phase. Thus, this leads to the growth of the market.
Restraints/Challenges
- Developing Quality Issues of Drugs
Numerous quality issues associated with marasmus drug preparations are also projected to impede the growth of the market. Several manufacturers are not obtaining WHO prequalification for manufacturing of marasmus treatment drugs causing the higher production of substandard quality of drugs in the market.
This marasmus treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the marasmus treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Marasmus Treatment Market Scope
The marasmus treatment market is segmented on the basis of treatment, mechanism of action, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Treatment
- Medication
- Dietary Supplements
- Nutritional Diet
Mechanism of Action
- Antimicrobial Agents
- Antiprotozoal Agents
- Antipyretics
- Analgesics
- Others
Route of Administration
- Oral
- Intravenous
- Others
End User
- Hospitals
- Specialty Clinics
- Diagnostic Centers
- Others
Distribution Channel
- Direct Tender
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
Marasmus Treatment Market Regional Analysis/Insights
The marasmus treatment market is analyzed and market size insights and trends are provided by treatment, mechanism of action, route of administration, distribution channel and end-user as referenced above.
The major countries covered in the marasmus treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Asia-Pacific is the fastest growing region as the demand for marasmus treatment are increasing very rapidly due to the growing healthcare expenditure and increasing awareness related with the marasmus symptoms.
North America is dominating the market because of the high occurrence of marasmus disease. The funding from regional governments, increased clinical developments and product launches are impacting the market growth positively.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of Global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Marasmus Treatment Market Share Analysis
The marasmus treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to marasmus treatment market.
Key players operating in the marasmus treatment market include:
- Par Pharmaceutical (U.S.)
- Groupe Lactalis (France)
- Nutricia (Netherlands)
- Fresenius SE & Co. KGaA (Germany)
- Abbott (U.S.)
- Altasciences (Canada)
- PepsiCo (U.S.)
- Nestlé, (Switzerland)
- Anaiah Healthcare Limited (U.K.)
- AYMES Nutrition (U.K.)
- Solvay (Belgium)
SKU-